Diabetes Mellitus, Type 1

Showing NaN - NaN of 42

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hypoglycaemia (Low Blood Sugar) in Diabetes and Adrenal Failure

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • +2 more
  • Continuous Glucose Monitoring
  • London, United Kingdom
    Charing Cross Hospital, Imperial College Healthcare NHS Trust
Apr 13, 2023

Diabetes, Type 1 Trial in Aurora, London, Toronto (Dapagliflozin 5mg, Placebo)

Recruiting
  • Diabetes Mellitus, Type 1
  • Dapagliflozin 5mg
  • Placebo
  • Aurora, Colorado
  • +2 more
Oct 31, 2022

Diabetes, Type 1 Trial in Worldwide (Verapamil SR 120 mg, Placebo)

Recruiting
  • Diabetes Mellitus, Type 1
  • Verapamil SR 120 mg
  • Placebo
  • Graz, Styria, Austria
  • +22 more
Jun 29, 2022

Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in London (Dexcom G6, Self monitoring of blood glucose)

Recruiting
  • Diabetes Mellitus
  • +5 more
  • Dexcom G6
  • Self monitoring of blood glucose
  • London, United Kingdom
    Imperial College Clinical Research Facility
Jun 23, 2022

Diabetes, Diabetes, Type 1 Trial in Worldwide (Insulin degludec, Insulin Aspart, Insulin detemir)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Insulin degludec
  • +2 more
  • Caba, Argentina
  • +70 more
Mar 29, 2022

Avoidance of Hyperglycaemia in People With Type 1 Diabetes

Completed
  • Diabetes Mellitus, Type 1
  • No intervention
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Apr 20, 2022

Diabetes, Diabetes, Type 2, Diabetes, Type 1 Trial in London (COMPASS: digital CBT)

Not yet recruiting
  • Diabetes Mellitus
  • +10 more
  • COMPASS: digital CBT
  • London, United Kingdom
    King's College London
Apr 6, 2022

Diabetes, Type 1 Trial in London (Youth Empowerment Skills, Waiting-list control)

Active, not recruiting
  • Diabetes Mellitus, Type 1
  • Youth Empowerment Skills
  • Waiting-list control
  • London, United Kingdom
  • +4 more
Mar 29, 2022

Diabetes, Type 1 Trial in London (BiAP, ABC4D)

Terminated
  • Diabetes Mellitus, Type 1
  • BiAP
  • ABC4D
  • London, United Kingdom
    Imperial College Clinical Research Facility
Mar 29, 2022

Diabetes, Type 1, Hypoglycemia Unawareness, Hypoglycemia Trial in London (Dexcom G6 CGM, Tandem t:slim X2 Insulin Pump)

Completed
  • Diabetes Mellitus, Type 1
  • +2 more
  • Dexcom G6 CGM
  • Tandem t:slim X2 Insulin Pump
  • London, United Kingdom
    Imperial College Clinical Research Facility
Mar 29, 2022

Diabetes, Type 1, Eating Disorders Trial in London (STEADY intervention)

Active, not recruiting
  • Diabetes Mellitus, Type 1
  • Eating Disorders
  • STEADY intervention
  • London, United Kingdom
    King's College Hospital
Jan 26, 2022

Contraception and Pregnancy in Diabetes Mellitus

Completed
  • Diabetes Mellitus, Type 1
  • Contraception
    • London, United Kingdom
      Imperial College London
    Sep 1, 2021

    Diabetes, Type 1 Trial in Worldwide (Accu-Chek® Solo micropump system, mylife™ OmniPod® Insulin Management System, Multiple

    Completed
    • Diabetes Mellitus, Type 1
    • Accu-Chek® Solo micropump system
    • +2 more
    • Feldkirch, Austria
    • +20 more
    Aug 19, 2021

    Diabetes, Type 1 Trial in Worldwide (Hydrolysed infant formula, Nonhydrolysed infant formula)

    Completed
    • Diabetes Mellitus, Type 1
    • Hydrolysed infant formula
    • Nonhydrolysed infant formula
    • Tampa, Florida
    • +17 more
    Jul 9, 2021

    Diabetes, Diabetes, Type 1 Trial in Worldwide (NNC0114-0006, liraglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • La Jolla, California
    • +107 more
    Mar 10, 2021

    Celiac Disease and Diabetes Longitudinal Follow-up and

    Completed
    • Celiac Disease
    • +2 more
      • Hamilton, Ontario, Canada
      • +5 more
      Mar 2, 2021

      Diabetes, Type 1 Trial in London (ARISES)

      Completed
      • Diabetes Mellitus, Type 1
      • ARISES
      • London, United Kingdom
        Imperial College Clinical Research Facility
      Aug 3, 2020

      Diabetes, Type 1 Trial in Worldwide (Albiglutide weekly injection, Placebo weekly injection, Insulin)

      Completed
      • Diabetes Mellitus, Type 1
      • Albiglutide weekly injection
      • +2 more
      • Bois-Guillaume, France
      • +31 more
      Jun 12, 2020

      Tresiba® After Switching Basal Insulin inPopulation With Type 1

      Completed
      • Diabetes Mellitus, Type 1
      • Diabetes Mellitus, Type 2
      • Insulin degludec
      • Calgary, Alberta, Canada
      • +31 more
      Dec 5, 2019

      Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart)

      Completed
      • Diabetes
      • Diabetes Mellitus, Type 1
      • Faster-acting insulin aspart
      • insulin aspart
      • Encino, California
      • +91 more
      Nov 12, 2019

      Insulin Degludec inReal World Population With Type 1 and 2

      Completed
      • Diabetes
      • +2 more
      • insulin degludec
      • Århus, Denmark
      • +7 more
      Sep 30, 2019

      Diabetes, Type 1 Trial in Worldwide (Metformin, Placebo)

      Completed
      • Diabetes Mellitus, Type 1
      • Melbourne, Australia
      • +23 more
      Jun 4, 2019

      Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin detemir, insulin aspart)

      Completed
      • Diabetes
      • Diabetes Mellitus, Type 1
      • Faster-acting insulin aspart
      • +2 more
      • Mobile, Alabama
      • +190 more
      May 28, 2019

      Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec/insulin aspart, insulin aspart, insulin detemir)

      Completed
      • Diabetes
      • Diabetes Mellitus, Type 1
      • insulin degludec/insulin aspart
      • +2 more
      • Phoenix, Arizona
      • +72 more
      Jun 3, 2019

      Diabetes, Type 1 Trial in Worldwide (Empagliflozin, Placebo)

      Completed
      • Diabetes Mellitus, Type 1
      • Escondido, California
      • +130 more
      Dec 12, 2018